Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 184A1 | NM | Basal | Trastuzumab | HER2 | ErbB | 0.288 | uM | 9047.026 | 1.0021 | 1.0071 | 0.5972 | |
| 184A1 | NM | Basal | Trastuzumab | HER2 | ErbB | 1.44 | uM | 9047.026 | 0.9465 | 0.8241 | 0.5972 | |
| 184A1 | NM | Basal | Trastuzumab | HER2 | ErbB | 7.2 | uM | 9047.026 | 0.7674 | 0.2837 | 0.5972 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 0.0000184 | uM | 9095.026 | 1.2976 | 1.5841 | 1.0168 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 0.0000922 | uM | 9095.026 | 1.1812 | 1.3559 | 1.0168 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 0.000461 | uM | 9095.026 | 1.2250 | 1.4418 | 1.0168 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 0.0023 | uM | 9095.026 | 1.1652 | 1.3246 | 1.0168 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 0.0115 | uM | 9095.026 | 1.1982 | 1.3893 | 1.0168 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 0.0576 | uM | 9095.026 | 1.1659 | 1.3259 | 1.0168 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 0.288 | uM | 9095.026 | 1.1851 | 1.3636 | 1.0168 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 1.44 | uM | 9095.026 | 1.1297 | 1.2549 | 1.0168 | |
| 184B5 | NM | Basal | Trastuzumab | HER2 | ErbB | 7.2 | uM | 9095.026 | 0.8550 | 0.7144 | 1.0168 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 0.0000184 | uM | 9146.122 | 0.9832 | 0.9749 | 1.3408 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 0.0000922 | uM | 9146.122 | 1.0936 | 1.1381 | 1.3408 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 0.000461 | uM | 9146.122 | 1.0769 | 1.1136 | 1.3408 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 0.0023 | uM | 9146.122 | 0.8246 | 0.7321 | 1.3408 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 0.0115 | uM | 9146.122 | 0.7730 | 0.6505 | 1.3408 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 0.0576 | uM | 9146.122 | 0.7820 | 0.6649 | 1.3408 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 0.288 | uM | 9146.122 | 0.7868 | 0.6726 | 1.3408 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 1.44 | uM | 9146.122 | 0.8250 | 0.7327 | 1.3408 | |
| AU565 | HER2amp | Luminal | Trastuzumab | HER2 | ErbB | 7.2 | uM | 9146.122 | 0.6801 | 0.5003 | 1.3408 | |
| BT-20 | TNBC | Basal A | Trastuzumab | HER2 | ErbB | 0.0000184 | uM | 5903.102 | 0.9807 | 0.9691 | 1.2557 | |
| BT-20 | TNBC | Basal A | Trastuzumab | HER2 | ErbB | 0.0000922 | uM | 5903.102 | 1.0124 | 1.0197 | 1.2557 | |
| BT-20 | TNBC | Basal A | Trastuzumab | HER2 | ErbB | 0.000461 | uM | 5903.102 | 1.0352 | 1.0559 | 1.2557 | |
| BT-20 | TNBC | Basal A | Trastuzumab | HER2 | ErbB | 0.0023 | uM | 5903.102 | 1.0661 | 1.1046 | 1.2557 |